Cefixime EP Impurity A
Product Description
CAT No.
ALN-C081002
CAS No.
1614255-90-1
Mol. F.
C16H17N5O8S2
Mol. Wt.
471.5
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 2-[[(Z)-2-(2-Aminothiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl]amino]-2-[(2R)-5-methyl-7-oxo-1,2,5,7-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl]acetic acid (as per EP)
Smiles : NC1=NC(/C(C(NC([C@@]2([H])SCC3=C(C(OC3C)=O)N2)C(O)=O)=O)=N/OCC(O)=O)=CS1
Inchi : InChI=1S/C16H15N5O7S2/c1-2-6-4-29-14-10(13(25)21(14)11(6)15(26)27)19-12(24)9(20-28-3-8(22)23)7-5-30-16(17)18-7/h2,5,10,14H,1,3-4H2,(H2,17,18)(H,19,24)(H,22,23)(H,26,27)/b20-9-/t10-,14-/m1/s1
Technical Data
Reference
Analytical method development and validation of cefixime and azithromycin by using RP-HPLC
By Sireesha, E.; Reddy, L. Ramachandra; Dhachinamoorthi, D.nFrom World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(9), 1160-1177
Stability indicating hplc method for the quantification of cefixime, ornidazole and moxifloxacin in solid dosage forms
By Palacharla, Suresh Kumar; Mohan, G. V. Krishna – From Rasayan Journal of Chemistry (2018), 11(4), 1696-1714
Validated stability-indicating HPTLC method for cefixime and azithromycin with preparative isolation, identification, and characterization of degradation products
By Gawande, V. T.; Bothara, K. G.; Satija, C. O. – From Acta Chromatographica (2018), 30(4), 212-218
RFQ